Shared Decision Making Assistant (SDMA) and other digital tools for choosing antipsychotics in schizophrenia treatment

Conflict of interest

In the last three years Stefan Leucht has received honoraria as advisor and/or for lectures and/or for educational material from Alkermes, Angelini, Apsen, Eisai, Gedeon Richter, Janssen, Karuna, Kynexis, Lundbeck, Medichem, Medscape, Merck Sharp and Dohme, Mitshubishi, Neurotorium, NovoNordisk, Otsuka, Recordati, Roche, Rovi, Sanofi Aventis, and TEVA. Alkomiet Hasan has been on the advisory boards of Janssen, Lundbeck, Recordati, Rovi and Otsuka and received speaker fees from those companies and from AbbVie. W. Strube has received a speaker’s honorarium from Mag&More GmbH and neurocare and was a member of the advisory board of Recordati. Spyridon Siafis, Alessandro Rodolico, Natalie L. Peter, Ingrid Bauer, Peter Brieger, none to declare. Johannes Hamann received lecture honoraria from Janssen, Otsuka, Lundbeck and Rovi.

Comments (0)

No login
gif